Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
5-year Survival
33%
Acute Lymphoblastic Leukemia
100%
African American
33%
Chemotherapy
33%
Childhood Acute Lymphoblastic Leukemia
66%
Ethnic Differences
66%
European American
33%
Extra Phase
33%
Genomic Variation
33%
Germ Cells
33%
Hispanic Ethnicity
33%
Large Cohort
33%
Native American
33%
Non-genetic Factors
33%
Over 80
33%
P Factor
33%
Pharmacogenomics
100%
Poor Survival
33%
Prognostic Factors
33%
Relapse Risk
100%
SNP Genotyping
33%
Biochemistry, Genetics and Molecular Biology
Genetic Determinism
100%
Genetics
100%
Genomics
100%
Germ Cell
100%
Germline
100%
Pharmacogenomics
100%
Single Nucleotide Polymorphism
100%
Survival Rate
100%
Immunology and Microbiology
Germ Cell
100%
Heredity
100%
Pharmacogenomics
100%
Single Nucleotide Polymorphism
100%
Survival Rate
100%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
Chemotherapy
25%
Five-Year Survival Rate
25%
Germ Cell
25%
Heredity
25%
Pharmacogenomics
100%
Prognostic Factor
25%
Single Nucleotide Polymorphism
25%